Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin

HIV Medicine
Weerawat ManosuthiSomnuek Sungkanuparph

Abstract

There is limited comparative data between efavirenz (EFV) 600 mg/day and nevirapine (NVP) 400 mg/day-based antiretroviral therapy (ART) among HIV-1 patients with tuberculosis (TB) and receiving rifampicin. A retrospective cohort study was conducted in all ART-naïve patients who were receiving rifampicin between January 2002 and December 2005. Of 188 patients, 77 and 111 patients were initiated on EFV-based ART (EFV group) and NVP-based ART (NVP group), respectively. Overall, median [interquartile range (IQR)] CD4 count was 36 (15-77) cells/microL and median (IQR) viral load was 5.6 (5.2-5.9) HIV-1 RNA log copies/mL. At 48 weeks, 77.9% (60/77) in the EFV group and 67.6% (75/111) in the NVP group achieved HIV-1 RNA <50 copies/mL (P=0.140, odds ratio=0.590, 95% confidence interval=0.302-1.153). At 24 and 48 weeks, respective median CD4 counts were 174 and 254 cells/muL in the EFV group and 156 and 218 cells/microL in the NVP group (P>0.05). By binary logistic regression, treatment group was not associated with HIV-1 RNA <50 copies/mL (P>0.05). No patient in the EFV group and eight (7.2%) patients in the NVP group discontinued ART because of adverse reactions (P=0.084). For HIV-TB co-infected patients who receive rifampicin, effica...Continue Reading

References

Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W M El-SadrD L Cohn
Dec 18, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·E RiberaA Pahissa
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mark S SulkowskiRichard D Moore
May 9, 2002·Archives of Internal Medicine·Christopher K FinchTimothy H Self
Oct 18, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jerry O SternDouglas L Mayers
Mar 17, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Melisse Sloas Baylor, Rosemary Johann-Liang
Feb 18, 2005·The Journal of Infectious Diseases·Ian SanneFranck Rousseau
Jun 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Weerawat ManosuthiKiat Ruxrungtham
Aug 4, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Weerawat ManosuthiSomnuek Sungkanuparph
Aug 15, 2006·JAMA : the Journal of the American Medical Association·Scott M HammerUNKNOWN International AIDS Society-USA panel
Aug 30, 2007·The Journal of Infectious Diseases·Paul NunnKevin M De Cock
Aug 31, 2007·The Journal of Infectious Diseases·Philip Chukwuka OnyebujohChristopher Curtis Whalen

❮ Previous
Next ❯

Citations

Feb 12, 2009·Journal of Biosciences·Soumya Swaminathan, G Nagendran
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gabriel ChamieDiane V Havlir
Jan 5, 2010·Current Opinion in HIV and AIDS·Karen Cohen, Graeme Meintjes
Apr 13, 2011·Clinical Microbiology Reviews·Candice K Kwan, Joel D Ernst
Nov 26, 2011·BMC Research Notes·Hadija H Semvua, Gibson S Kibiki
Jun 30, 2011·Drugs·Kartik K VenkateshKenneth H Mayer
Feb 9, 2012·The Indian Journal of Medical Research·C PadmapriyadarsiniSoumya Swaminathan
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Soumya SwaminathanRanjani Ramachandran
Jan 6, 2011·Expert Opinion on Drug Safety·Tanuja N GengiahQuarraisha Abdool Karim
Oct 1, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Weerawat ManosuthiSomnuek Sungkanuparph
Oct 15, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·C PadmapriyadarsiniSoumya Swaminathan
Jun 10, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hai-Yin JiangBing Ruan
May 18, 2016·AIDS Research and Therapy·Weerawat ManosuthiSomnuek Sungkanuparph
Feb 13, 2009·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Massimo PuotiGiampiero Carosi
Sep 5, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Alberto MatteelliMathurin Dembele
May 18, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Weerawat ManosuthiUNKNOWN TIME Study Team

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.